Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,416.00    -14.00 (-0.98%)
Bid:
1,420.00
Ask:
1,426.00
Spread: 6.00 (0.423%)
Market Cap: £484.80m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

Significant Contract Win

31 Oct 2017 07:00

RNS Number : 0253V
Craneware plc
31 October 2017
 

Craneware plc

("Craneware", "the Group" or the "Company")

 

Significant Contract Win

 

31 October 2017 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, is pleased to announce the renewal and significant expansion of an existing contract with a growing hospital operator in the US.

 

This $6m win sees the extension of a relationship that has been in place since 2007, with the renewal of the customer's existing Value Cycle solutions and the roll out of these same solutions to further facilities that have been recently acquired by this hospital network. The contract is expected to deliver $3.5m of incremental revenue over this new five year term as the hospital network rolls out these solutions at its additional facilities.

 

In accordance with the Company's revenue recognition policy, the majority of the revenue resulting from this contract will be recognised over future periods, adding to the Group's long term visibility of revenue under contract.

 

Keith Neilson, CEO of Craneware plc, commented, "The expansion of this relationship demonstrates the strategic importance of Craneware's Value Cycle solutions to our customers, as they extend their own hospital networks throughout the US. The strength of our solutions and the value they deliver to all customers, including large and complex health systems, allows us to deepen our relationship with our customers as they address the challenges resulting from the continued evolution to the new value based re-imbursement environment.

 

"Having enjoyed our positive working relationship for a decade, we now look forward to continuing to deliver sustainable value throughout this new term."

For further information, please contact:

 

Craneware plc

Peel Hunt

Alma

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)208 004 4218

Keith Neilson, CEO

Dan Webster

Caroline Forde

Craig Preston, CFO

Adrian Trimmings

George Sellar

Hilary Buchanan

Robyn McConnachie

Josh Royston

 

About Craneware

 

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

 

Craneware is the leader in automated value cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta, Boston and Phoenix employing over 250 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTGMMFGLGLGNZM
Date   Source Headline
2nd Jun 20117:00 amRNSInvestor and Analyst Presentation
2nd Jun 20117:00 amRNSCraneware InSight Contract Win
31st May 201112:24 pmRNSTotal Voting Rights
24th May 20117:00 amRNSDirector Declaration
28th Apr 20112:42 pmRNSTotal Voting Rights
27th Apr 201112:25 pmRNSBlocklisting Interim Review
27th Apr 201110:02 amRNSHolding(s) in Company
19th Apr 20115:28 pmRNSHolding(s) in Company
8th Apr 20114:18 pmRNSHolding(s) in Company
7th Apr 20114:49 pmRNSHolding(s) in Company
7th Apr 20113:52 pmRNSBlocklisting Application
7th Apr 20118:53 amRNSHolding(s) in Company
5th Apr 20112:11 pmRNSDirector Shareholding & Issue of Equity
1st Apr 20115:27 pmRNSAdditional Listing
31st Mar 20115:51 pmRNSTotal Voting Rights
25th Mar 20114:27 pmRNSHolding(s) in Company
25th Mar 20113:45 pmRNSDividend Currency Election
24th Mar 20117:00 amRNSAdditional Listing
17th Mar 20115:19 pmRNSDirector/PDMR Shareholding
15th Mar 201111:32 amRNSAdditional Listing
10th Mar 20115:27 pmRNSAdditional Listing
10th Mar 20115:22 pmRNSHolding(s) in Company
10th Mar 20115:18 pmRNSHolding(s) in Company
2nd Mar 20117:00 amRNSDirector & PDMR Shareholding
28th Feb 20114:31 pmRNSAdditional Listing
28th Feb 20113:46 pmRNSDirector/PDMR Shareholding
28th Feb 20117:00 amRNSHalf Yearly Report
18th Feb 20117:00 amRNSAcquisition of ClaimTrust
28th Jan 20118:26 amRNSHolding(s) in Company
25th Jan 20117:00 amRNSTrading Update & Notice of Results
21st Dec 20104:38 pmRNSAdviser - Change of Name
12th Nov 20108:19 amRNSDividend Currency Election
9th Nov 20102:34 pmRNSHolding(s) in Company
9th Nov 20102:22 pmRNSHolding(s) in Company
2nd Nov 20107:00 amRNSAGM Statement
19th Oct 20107:10 amRNSBlocklisting Interim Review
19th Oct 20107:00 amRNSPosting of Annual Report and Accounts
8th Oct 201012:44 pmRNSHolding(s) in Company
28th Sep 20107:00 amRNSContract Win for Supplies ChargeLink
22nd Sep 20107:00 amRNSHolding(s) in Company
9th Sep 20102:47 pmRNSDirector/PDMR Shareholding
8th Sep 20107:00 amRNSDirector/PDMR Shareholding
6th Sep 20107:00 amRNSFinal Results
10th Aug 20107:00 amRNSNotice of Final Results
14th Jul 20107:00 amRNSTrading Update
9th Jul 20107:00 amRNSLaunch of ADR Programme
22nd Apr 20104:08 pmRNSHolding(s) in Company-Amendment
22nd Apr 20102:27 pmRNSHolding(s) in Company
21st Apr 20103:41 pmRNSDirectors Shareholding
21st Apr 20107:00 amRNSReseller Agreement with Premier

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.